Ticker Details
Vir Biotechnology, Inc.
IPO Date:	October 11, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.05B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.82 | 3.13%
Avg Daily Range (30 D):	$0.25 | 3.58%
Avg Daily Range (90 D):	$0.20 | 3.20%

Institutional Daily Volume
Avg Daily Volume:	1.04M
Avg Daily Volume (30 D):	2.95M
Avg Daily Volume (90 D):	1.93M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	105
Avg Trade Size (Sh.) (90 D):	100

Institutional Trades
Total Institutional Trades:	3,127
Avg Institutional Trade:	$2.43M
Avg Institutional Trade (30 D):	$1.28M
Avg Institutional Trade (90 D):	$1.2M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.44M
Avg Closing Trade (30 D):	$1.47M
Avg Closing Trade (90 D):	$1.34M
Avg Closing Volume:	181.86K

News

Feb 24, 2026 @ 1:31 PM Stock Market Today: S&P 500 Futures Slip As Dow, N... Source: Rishabh Mishra

Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights

Aug 7, 2025 @ 4:32 AM Vir (VIR) Q2 Revenue Drops 61% Source: Jesterai

Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research

Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-1.17	$-.8
Diluted EPS		$-1.17	$-.8
Revenue		$.24M	$1.21M
Gross Profit			$1.2M
Net Income / Loss		$-163.14M	$-110.96M
Operating Income / Loss		$-173.44M	$-118.42M
Cost of Revenue			$.01M
Net Cash Flow		$-127.02M	$-61.72M
PE Ratio